← All trials
NCT04598880
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 6, 2020
- Primary completion
- May 31, 2021
- Completion date
- May 31, 2021
- First posted
- Oct 22, 2020
- Last posted
- Dec 17, 2020
- Enrollment
- 1104
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Institut Hospital del Mar d'Investigacions MèdiquesLead sponsor
- Clinica Universidad de NavarraOverall official - principal investigator
- Hospital del Mar (Barcelona, Spain)Overall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.